drug delivery
Tag details
Welcome to the 'drug delivery' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'drug delivery'.
Latest blogosphere posts tagged “drug delivery”
-
(ALKS) Alkermes Moves to Loss but Beats Consensus Estimates
Stock Blog Hub —
Authority: 506
Alkermes, Inc. ( ALKS ) reported a second quarter fiscal 2010 net loss of 5 cents per share, compared with a profit of 2 cents in the year-ago period. The Zacks Consensus Estimate was a loss of 10 cents. Revenues in the quarter increased 1.9 % to $48.2 million from $47.3 million in the year-ago quarter. The increase ...8 hours ago -
DES and other coronary artery disease treatment tech trends
advanced medical technologies —
Authority: 128
A steady rate of technology development in coronary stents, producing an equally steady stream of new stent market introductions, is focused on expanding aggregate stent caseload (through penetration of what would otherwise be coronary artery bypass caseload) or shifting the balance even further toward concentration ...9 hours ago -
Nanosized drug delivery systems take a leap forward
Innovation Toronto —
Authority: 439
Blood vessels that supply tumors are more porous than normal vessels, makes nanoscale drug delivery systems a particularly attractive prospect. If properly engineered, nanoparticles can in fact get inside a tumor, targeting it precisely and allowing much higher drug dosages as they reduce side effects to a minimum. ...13 hours ago -
NuPathe ready with new drug application for migraine treatment
Pharmamics —
Authority: 129
NuPathe Inc., the Conshohocken specialty pharmaceutical company that is getting ready to file a new drug application for its experimental migraine headache treatment, has expanded its partnership formed in 2007 to take on Parkinson’s disease.Late Monday, NuPathe entered into a license agreement for drug-delivery ...5 days ago -
Nanoporous contact lens technology. Photochromic contact lens. Singapore. IBN. NUH. “… Flagship project, coupled with an S$5 million funding, to help set up IBN iCare and NUH Eye Centre @ Biopolis.”
LASIK Eye Surgery —
Authority: 132
In Singapore, Boon Swan Foo, the Executive Chairman of Exploit Technologies has informed: “The bringing together of clinicians with scientists and commercial people to this juncture is due to the unrelenting effort of the key players, including Dr. Muhammad Tani, Professor Jackie Ying and Associate Professor Paul ...6 days ago -
New nano-scale drug delivery system for chemotherapy
Thaindian News —
Authority: 725
London, Nov 2 (ANI): A research team led by Indian-origin scientist has developed a nano-scale drug delivery method that has been found to effectively eliminate cancer tumours after a single treatment.The Duke University study conducted over animal models revealed that after delivering the drug to the tumour, the ...1 week ago -
Duke develops nano-scale drug delivery for chemotherapy
emedist.com —
Authority: 159
(Duke University) Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation [...]1 week ago -
Duke develops nano-scale drug delivery for chemotherapy
Science Blog - Science news straight from the source —
Authority: 617
DURHAM, N.C. -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs.1 week ago -
Duke develops nano-scale drug delivery for chemotherapy
Health Fitness & Beauty - health-fitness.marc8.com —
Authority: 158
(Duke University) Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment.1 week ago -
The Daily Habit: Weird News
The 115- Fear and Loathing in America: Random Babble from the Red-Eyed Counterculture —
Authority: 140
11:59 pm I Drove the Truck and my Mom Sold the Smack - GLOUCESTER, MASSACHUSETTS - There is nothing in this world that compares to the love a mother has for her son, and vice versa. Some say it’s genetic, others say it’s a mother’s instinct, but either way it’s one hell of a ...1 week ago -
(NKTR) The F.I.R.S.T. System: Searching For the “Holy Grail” of Investing
Stock Blog Hub —
Authority: 506
by Marc Lichtenfeld , Healthcare Expert Wednesday, October 28, 2009: Issue #1125 When it comes to investing, how do you find the “Holy Grail?” Does it even exist? Over my 19 years of stock market experience, I’ve searched high and low for the answers. One of my first steps was to plow into technical ...1 week ago -
(HSP) Hospira Surges Ahead
Stock Blog Hub —
Authority: 506
Hospira ( HSP ) reported third quarter earnings of 90 cents per share, well above both the Zacks Consensus Estimate of 68 cents and 63 cents per share in the year-ago period. Revenues increased 8.9% to $1 billion, primarily driven by growth in Specialty Injectable Pharmaceuticals (SIP). SIP revenues increased 25.6% ...1 week ago -
Ligand to Buy Struggling Metabasis
OneMedPlace —
Authority: 123
Ligand Pharmaceuticals has agreed to buy the struggling Metabasis Therapeutics for $3.2 million in cash. Metabasis will receive approximately $1.8 million after net liabilities are factored in. The purchase is a positive development for La Jolla, Calif.-based Metabasis, which announced in June that it might ...1 week ago -
Novel optimised inhaler mouthpiece facilitates more effective drug delivery
Thaindian News —
Authority: 725
Washington, Oct 22 (ANI): A newly developed optimised mouthpiece design can aid efficient drug delivery to the lungs by reducing the amount of medication wasted as it passes through the mouthpiece of an aerosol inhaler.With current inhaler designs, only approximately 10 to 20 percent of asthma medications are ...2 weeks ago -
(PETS) PetMed Express In-Line with Consensus Estimates
Stock Blog Hub —
Authority: 506
PetMed Express, Inc . (PETS), the America ’s largest Pet Pharmacy, recently reported second-quarter 2010 results. The quarterly earnings of 28 cents a share came in line with the Zacks Consensus Estimate but rose 12% year-on-year from 25 cents posted in the prior-year quarter. Net sales climbed 5% to $62.4 million ...2 weeks ago -
Optimized inhaler mouthpiece design allows for more effective drug delivery
Science Blog - Science news straight from the source —
Authority: 617
Researchers have developed an optimized mouthpiece design to aid efficient drug delivery to the lungs by reducing the amount of medication wasted as it passes through the mouthpiece of an aerosol inhaler. With current inhaler designs, only approximately 10 to 20 percent of asthma medications are delivered to the lungs.2 weeks ago -
Coronary stents: Big differences in adoption globally
advanced medical technologies —
Authority: 113
Market drivers that vary geographically account for some big differences in the distribution of the coronary stent market across the currently available stent types, and these differences will continue when bioabsorbable stents (and others) are introduced to the market over the next few years. The local market ...3 weeks ago -
(ALKS) Good News for Alkermes’ Drug Pipeline
Stock Blog Hub —
Authority: 506
Recently, Alkermes Inc. (ALKS) announced that its pipeline candidate, ALKS33, for addiction and nervous system disorders, gave positive results in two early stage clinical trials. Results from the two studies, ALK33-003 and ALK33-004, demonstrated that the candidate blocked the effects of an opioid with an action ...3 weeks ago -
Trinity Researchers Develop New Drug Delivery System for Retinal Disease
Pharmamics —
Authority: 129
Researchers at the Smurfit Institute of Genetics’ Ocular Genetics Unit at Trinity College Dublin have reported the development of a new drug delivery system which has the potential to treat degenerative diseases of the retina, including retinitis pigmentosa, age-related macular degeneration and diabetic retinopathy, ...3 weeks ago -
(ELN) SEC Subpoena for Elan Regarding Tysabri Use Disclosure
Stock Blog Hub —
Authority: 506
Elan Corporation (ELN) recently received a subpoena from the US Securities and Exchange Commission (SEC) regarding the company’s disclosure of two brain disorder cases (in July 2008), often fatal, tied to the use of its drug Tysabri for the treatment of multiple sclerosis. Elan has a marketing agreement with ...3 weeks ago